Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Bmi1 is required for hepatic progenitor cell expansion and liver tumor development.
Fan L, Xu C, Wang C, Tao J, Ho C, Jiang L, Gui B, Huang S, Evert M, Calvisi DF, Chen X.
PLoS One. 2012;7(9):e46472. doi: 10.1371/journal.pone.0046472. Epub 2012 Sep 28.
Related citations
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.
Wang C, Delogu S, Ho C, Lee SA, Gui B, Jiang L, Ladu S, Cigliano A, Dombrowski F, Evert M, Calvisi DF, Chen X.
J Hepatol. 2012 Sep;57(3):577-83. doi: 10.1016/j.jhep.2012.04.026. Epub 2012 May 19.
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.
Ho C, Wang C, Mattu S, Destefanis G, Ladu S, Delogu S, Armbruster J, Fan L, Lee SA, Jiang L, Dombrowski F, Evert M, Chen X, Calvisi DF.
Hepatology. 2012 Mar;55(3):833-45. doi: 10.1002/hep.24736. Epub 2011 Dec 19.
Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.
Lee SA, Ladu S, Evert M, Dombrowski F, De Murtas V, Chen X, Calvisi DF.
Hepatology. 2010 Aug;52(2):506-17. doi: 10.1002/hep.23681.
Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.
Xu CR, Lee S, Ho C, Bommi P, Huang SA, Cheung ST, Dimri GP, Chen X.
Mol Cancer Res. 2009 Dec;7(12):1937-45. doi: 10.1158/1541-7786.MCR-09-0333. Epub 2009 Nov 24.
Cholangiocarcinomas can originate from hepatocytes in mice.
Fan B, Malato Y, Calvisi DF, Naqvi S, Razumilava N, Ribback S, Gores GJ, Dombrowski F, Evert M, Chen X, Willenbring H.
J Clin Invest. 2012 Aug 1;122(8):2911-5. doi: 10.1172/JCI63212. Epub 2012 Jul 17.
RNA interference as therapeutics for hepatocellular carcinoma.
Xu C, Lee SA, Chen X.
Recent Pat Anticancer Drug Discov. 2011 Jan;6(1):106-15. Review.
Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis.
Patil MA, Lee SA, Macias E, Lam ET, Xu C, Jones KD, Ho C, Rodriguez-Puebla M, Chen X.
Cancer Res. 2009 Jan 1;69(1):253-61. doi: 10.1158/0008-5472.CAN-08-2514.
Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development.
Kosinski C, Stange DE, Xu C, Chan AS, Ho C, Yuen ST, Mifflin RC, Powell DW, Clevers H, Leung SY, Chen X.
Gastroenterology. 2010 Sep;139(3):893-903. doi: 10.1053/j.gastro.2010.06.014. Epub 2010 Jun 11.
Hedgehog signaling in human hepatocellular carcinoma.
Patil MA, Zhang J, Ho C, Cheung ST, Fan ST, Chen X.
Cancer Biol Ther. 2006 Jan;5(1):111-7. Epub 2006 Jan 5.
Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer.
Lee SA, Ho C, Roy R, Kosinski C, Patil MA, Tward AD, Fridlyand J, Chen X.
Hepatology. 2008 Apr;47(4):1200-10. doi: 10.1002/hep.22169.
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, Brozzetti S, Staniscia T, Chen X, Dombrowski F, Evert M.
Gastroenterology. 2011 Mar;140(3):1071-83. doi: 10.1053/j.gastro.2010.12.006. Epub 2010 Dec 11.
Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors.
Kosinski C, Li VS, Chan AS, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST, Leung SY, Chen X.
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15418-23. Epub 2007 Sep 19.
Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X.
Carcinogenesis. 2005 Dec;26(12):2050-7. Epub 2005 Jul 6.
An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma.
Patil MA, Chua MS, Pan KH, Lin R, Lih CJ, Cheung ST, Ho C, Li R, Fan ST, Cohen SN, Chen X, So S.
Oncogene. 2005 May 26;24(23):3737-47.
Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.
Kakar S, Chen X, Ho C, Burgart LJ, Adeyi O, Jain D, Sahai V, Ferrell LD.
Histopathology. 2009 Aug;55(2):197-205. doi: 10.1111/j.1365-2559.2009.03343.x.
Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization.
Kakar S, Chen X, Ho C, Burgart LJ, Sahai V, Dachrut S, Yabes A, Jain D, Ferrell LD.
Mod Pathol. 2009 Jan;22(1):134-41. doi: 10.1038/modpathol.2008.178. Epub 2008 Nov 7.
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T, Matés JM, Alonso FJ, Wang C, Seo Y, Chen X, Bishop JM.
Cell Metab. 2012 Feb 8;15(2):157-70. doi: 10.1016/j.cmet.2011.12.015.
Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma.
Furge KA, Dykema KJ, Ho C, Chen X.
BMC Genomics. 2005 May 9;6:67.
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms.
Yan H, Chen X, Zhang Q, Qin J, Li H, Liu C, Calhoun-Davis T, Coletta LD, Klostergaard J, Fokt I, Skora S, Priebe W, Bi Y, Tang DG.
PLoS One. 2011;6(9):e24397. doi: 10.1371/journal.pone.0024397. Epub 2011 Sep 15.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on